Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H23Cl2N3OS.ClH |
Molecular Weight | 484.869 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN1CCN(CC1)C2=CC=CC=C2\C=C3/SCCN(C3=O)C4=CC=C(Cl)C(Cl)=C4
InChI
InChIKey=NMTRXBJYASHMND-UXTSPRGOSA-N
InChI=1S/C22H23Cl2N3OS.ClH/c1-25-8-10-26(11-9-25)20-5-3-2-4-16(20)14-21-22(28)27(12-13-29-21)17-6-7-18(23)19(24)15-17;/h2-7,14-15H,8-13H2,1H3;1H/b21-14-;
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C22H23Cl2N3OS |
Molecular Weight | 448.409 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Elzasonan (CP 448187) is a serotonin 1B/1D receptor antagonist. Elzasonan was primarily metabolized via oxidative N‐demethylation, N‐oxidation, and aryl hydroxylation. Pfizer was developing elzasonan for the treatment of anxiety and affective disorders however development has been discontinued.
CNS Activity
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:35:16 GMT 2023
by
admin
on
Fri Dec 15 15:35:16 GMT 2023
|
Record UNII |
X38F62RR8L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66885
Created by
admin on Fri Dec 15 15:35:16 GMT 2023 , Edited by admin on Fri Dec 15 15:35:16 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2110932
Created by
admin on Fri Dec 15 15:35:16 GMT 2023 , Edited by admin on Fri Dec 15 15:35:16 GMT 2023
|
PRIMARY | |||
|
X38F62RR8L
Created by
admin on Fri Dec 15 15:35:16 GMT 2023 , Edited by admin on Fri Dec 15 15:35:16 GMT 2023
|
PRIMARY | |||
|
C73806
Created by
admin on Fri Dec 15 15:35:16 GMT 2023 , Edited by admin on Fri Dec 15 15:35:16 GMT 2023
|
PRIMARY | |||
|
220322-05-4
Created by
admin on Fri Dec 15 15:35:16 GMT 2023 , Edited by admin on Fri Dec 15 15:35:16 GMT 2023
|
PRIMARY | |||
|
300000044593
Created by
admin on Fri Dec 15 15:35:16 GMT 2023 , Edited by admin on Fri Dec 15 15:35:16 GMT 2023
|
PRIMARY | |||
|
MM-16
Created by
admin on Fri Dec 15 15:35:16 GMT 2023 , Edited by admin on Fri Dec 15 15:35:16 GMT 2023
|
PRIMARY | |||
|
205683-38-1
Created by
admin on Fri Dec 15 15:35:16 GMT 2023 , Edited by admin on Fri Dec 15 15:35:16 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
6506051
Created by
admin on Fri Dec 15 15:35:16 GMT 2023 , Edited by admin on Fri Dec 15 15:35:16 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |